Desktop Site
|
18 Jul 24 | 12:19
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
BSE SENSEX
80,787.95
+71.40
+0.09 %
Corporate Announcement
Security Code
506197
Company
Bliss GVS Pharma Ltd
Exchange Received Time
22/06/2024 13:13:21
Exchange Disseminated Time
22/06/2024 13:13:22
Time Taken
00:00:01
Intimation Regarding The Appointment Of Additional Non-Executive Independent Director |
6/22/2024 1:13:22 PM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that, subject to approval of shareholders in ensuing 39th Annual General Meeting and based on recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company through circular resolution approved on June 22, 2024 have appointed Dr. Nandkumar Kashinath Chodankar (DIN:02736718) as a Additional Director in the category of Non-Executive Independent Director of the Company for a period of 5 yrs w.e.f. June 22, 2024. Please find enclosed the intimation is this regard.
Attachment
<< Back
Recently Viewed